Tag Archives: HIV/AIDS

Challenges in the March Toward an AIDS-Free Generation

FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.
Posted in Biotech, Events, FDA, healthcare, Market Access, Patient Communication, patient compliance, patient education, pricing, Regulatory, Safety | Also tagged , , , , , , | Leave a comment

Affordable Access to HIV Meds on the Way

UNITAID’s Medicines Patent Pool seeks to bring costly HIV/AIDS treatments and other essential drugs to low-income countries by requiring patent-holders to license their technologies to generics manufacturers. Will pledges of support from the NIH bring some of these patent-holders back to the negotiating table? A new way for patients to have access to affordable HIV […]
Posted in Deals, Manufacturing | Also tagged , , | Leave a comment
  • Categories

  • Meta